NCT02389881View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-058

TAK-058 Solution

DRUG

TAK-058 Placebo

TAK-058 placebo-matching solution

Trial Locations (1)

Unknown

Austsitn

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY